Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE

Mid Cap | Pharmaceuticals & Drugs

891.55

17.90 (2.05%)

< Home < Back

Zydus Lifesciences Ltd. News

>>

Zydus Lifesciences informs about newspaper publication

>>

Zydus Lifesceinces informs about press release

>>

Cadila Healthcare trades higher on the bourses

>>

Zydus Cadila gets USFDA’s final approval for Dapagliflozin Tablets

>>

Cadila Healthcare informs about press release

>>

Cadila Healthcare informs about loss of share certificate

>>

Cadila Healthcare informs about press release

>>

Zydus Cadila’s arm gets USFDA’s final approval for Roflumilast Tablets

>>

Cadila Healthcare informs about loss of share certificate

>>

Cadila Healthcare - Quaterly Results

<< < 68 69 70 ...168 > >>